These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1694267)

  • 21. Cerebral vasospasm caused by cisternal injection of polystyrene latex beads in rabbits is inhibited by a serine protease inhibitor.
    Yanamoto H; Kikuchi H; Okamoto S; Nozaki K
    Surg Neurol; 1994 Nov; 42(5):374-81. PubMed ID: 7974140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A model for intracranial vasospasm in subarachnoid hemorrhage].
    Jin Y; Proust F; Rabehenoina A; Seigneur N; Creissard P; Tadie M
    Neurochirurgie; 1991; 37(1):44-9. PubMed ID: 2017293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The experimental study of the cerebral vasospasm--the micro-circulation on the hypothalamus and the brain stem (author's transl)].
    Katsumata T
    No Shinkei Geka; 1975 Nov; 3(11):939-46. PubMed ID: 1240614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral vasospasm after subarachnoid hemorrhage.
    Chyatte D; Sundt TM
    Mayo Clin Proc; 1984 Jul; 59(7):498-505. PubMed ID: 6376963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rat femoral artery model for vasospasm.
    Okada T; Harada T; Bark DH; Mayberg MR
    Neurosurgery; 1990 Sep; 27(3):349-56. PubMed ID: 2234326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental cerebral vasospasm. 1: Factors contributing to early spasm.
    Nagai H; Suzuki Y; Sugiura M; Noda S; Mabe H
    J Neurosurg; 1974 Sep; 41(3):285-92. PubMed ID: 4413369
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of neonatal 6-hydroxydopamine treatment on experimental vasospasm following a subarachnoid hemorrhage in the rat.
    Delgado TJ; Arbab MA; Rosengren E; Svendgaard NA
    J Cereb Blood Flow Metab; 1987 Jun; 7(3):289-94. PubMed ID: 3108269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo characterization of vasocontractile activities in erythrocytes.
    McIlhany MP; Johns LM; Leipzig T; Patronas NJ; Brown FD; Mullan SF
    J Neurosurg; 1983 Mar; 58(3):356-61. PubMed ID: 6827319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of selective lesions in the hypothalamic-pituitary region on the development of cerebral vasospasm following an experimental subarachnoid hemorrhage in the rat.
    Svendgaard NA; Delgado TJ; Brun A
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):650-7. PubMed ID: 3793800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reversal of experimental cerebral vasospasm by neuropeptides].
    Nozaki K
    Nihon Geka Hokan; 1990 Jan; 59(1):55-67. PubMed ID: 2130769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation of vasospasm and intracranial metabolism under experimental subarachnoid hemorrhage--Part 1. In reference with the acid-base-balance of cerebral blood and cerebrospinal fluid].
    Takahashi S
    No To Shinkei; 1978 Jul; 30(7):777-87. PubMed ID: 28740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
    Gavras H; Andrews P; Papadakis N
    J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
    Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT
    J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic cerebral vasospasm: effect of calcium antagonists.
    Zabramski J; Spetzler RF; Bonstelle C
    Neurosurgery; 1986 Feb; 18(2):129-35. PubMed ID: 3960287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of intravascular components in cerebral vasospasm following subarachnoid hemorrhage.
    Hasegawa T; Watanabe H; Ishii S
    Neurosurg Rev; 1980; 3(2):93-100. PubMed ID: 7231687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intracisternal methylprednisolone on lipid peroxidation in experimental subarachnoid haemorrhage.
    Shibata S; Suzuki S; Ohkuma H; Kimura M; Fujita S
    Acta Neurochir (Wien); 1999; 141(5):529-32. PubMed ID: 10392211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasospasm and cerebral blood flow after subarachnoid hemorrhage.
    Ritchie WL; Overton TR
    J Can Assoc Radiol; 1980 Dec; 31(4):230-3. PubMed ID: 6778882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral arterial spasm. 3. In vivo intracisternal production of spasm by serotonin and blood and its reversal by phenoxybenzamine.
    Allen GS; Gold LH; Chou SN; French LA
    J Neurosurg; 1974 Apr; 40(4):451-8. PubMed ID: 4814376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.